Ameriprise’s Benefitfocus, Inc. BNFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,820
Closed -$389K 4027
2022
Q1
$389K Sell
30,820
-2,503
-8% -$26.7K ﹤0.01% 3560
2021
Q4
$355K Buy
33,323
+2,443
+8% +$26.2K ﹤0.01% 3620
2021
Q3
$343K Sell
30,880
-660
-2% -$8.02K ﹤0.01% 3521
2021
Q2
$445K Hold
31,540
﹤0.01% 3498
2021
Q1
$436K Hold
31,540
﹤0.01% 3463
2020
Q4
$457K Sell
31,540
-240
-0.8% -$2.93K ﹤0.01% 3380
2020
Q3
$356K Buy
31,780
+1,473
+5% +$16.2K ﹤0.01% 3368
2020
Q2
$326K Buy
+30,307
New +$332K ﹤0.01% 3336
2019
Q1
Sell
-25,446
Closed -$1.16M 3793
2018
Q4
$1.16M Buy
+25,446
New +$1.06M ﹤0.01% 2886
2017
Q3
Sell
-20,438
Closed -$743K 3780
2017
Q2
$743K Buy
+20,438
New +$656K ﹤0.01% 3080
2016
Q4
Sell
-31,693
Closed -$1.26M 3967
2016
Q3
$1.26M Buy
+31,693
New +$1.3M ﹤0.01% 2817
2014
Q4
Sell
-25
Closed -$1K 4564
2014
Q3
$1K Buy
25
+10
+67% +$365 ﹤0.01% 5609
2014
Q2
$1K Sell
15
-147,638
-100% -$5.53M ﹤0.01% 5400
2014
Q1
$6.94M Buy
147,653
+45,199
+44% +$2.84M ﹤0.01% 1820
2013
Q4
$5.92M Buy
102,454
+68,029
+198% +$3.31M ﹤0.01% 1895
2013
Q3
$1.69M Buy
+34,425
New +$1.69M ﹤0.01% 2517

Other funds holding BNFT

Ameriprise's BNFT Position: Q2 2022 in Review

Ameriprise sold out of Benefitfocus, Inc. (BNFT) in Q2 2022, closing a stake of 30,820 shares — an estimated $389K sold.

Ameriprise first reported a position in BNFT in Q3 2013 and held it in 16 quarters. The position peaked at $6.94M in Q1 2014. 100 funds tracked by Wall St. Rank hold BNFT as of Q2 2022.

  • Ameriprise reported no remaining Benefitfocus, Inc. position as of Q2 2022 after selling out during the quarter.
  • Ameriprise sold 30,820 Benefitfocus, Inc. shares in Q2 2022, an estimated $389K.
  • Ameriprise first reported a position in Benefitfocus, Inc. in Q3 2013 and held it in 16 quarters.
  • Ameriprise's Benefitfocus, Inc. position peaked at $6.94M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Benefitfocus, Inc. as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.